14 results on '"Billakanty S"'
Search Results
2. A critical decrease in dominant frequency and clinical outcome after catheter ablation of persistent atrial fibrillation.
- Author
-
Yoshida K, Chugh A, Good E, Crawford T, Myles J, Veerareddy S, Billakanty S, Wong WS, Ebinger M, Pelosi F, Jongnarangsin K, Bogun F, Morady F, Oral H, Yoshida, Kentaro, Chugh, Aman, Good, Eric, Crawford, Thomas, Myles, James, and Veerareddy, Srikar
- Abstract
Background: Termination of persistent atrial fibrillation (AF) by radiofrequency ablation (RFA) is associated with a high probability of freedom from AF but requires extensive ablation and long procedure times.Objective: The purpose of this study was to determine whether a critical decrease in the dominant frequency (DF) of AF is a sufficient endpoint for RFA of persistent AF.Methods: Antral pulmonary vein isolation (APVI) followed by RFA of complex fractionated atrial electrograms (CFAEs) in the atria and coronary sinus was performed in 100 consecutive patients with persistent AF. The DF of AF in lead V1 and in the coronary sinus was determined by fast Fourier transform (FFT) analysis at baseline and before termination of AF to identify a critical decrease in DF predictive of sinus rhythm after RFA.Results: A > or =11% decrease in DF had the highest accuracy in predicting freedom from atrial arrhythmias, with a sensitivity of 0.71 and a specificity of 0.82 (P <.001). At a mean follow-up of 14 +/- 3 months after one ablation procedure, sinus rhythm was maintained off antiarrhythmic drugs in 8/35 (23%) and 20/26 (77%) of patients with a <11% and > or =11% decrease in DF, respectively (P <.001). Sinus rhythm was maintained in 24/39 patients (62%) in whom RFA terminated AF. The duration of RFA and total procedure time were longer in patients with AF termination (95 +/- 23 and 358 +/- 87 minutes) than in patients with a <11% decrease in the DF (77 +/- 16 and 293 +/- 70 minutes) or > or =11% decrease in DF (80 +/- 17 and 289 +/- 73 minutes), respectively (P <.01). Among the variables of age, gender, left atrial diameter, duration of AF, left ventricular ejection fraction, duration of RFA, a > or =11% decrease in DF, and termination of AF, a > or =11% decrease in DF (odds ratio = 9.89, 95% confidence interval [CI] 2.84-34.47) and termination during RFA (OR = 4.38, 95% CI 1.50-12.80) were the only independent predictors of freedom from recurrent atrial arrhythmias.Conclusion: In a retrospective analysis of consecutive patients with persistent AF, a decrease in the DF of AF by 11% in response to APVI and ablation of CFAEs was associated with a probability of maintaining sinus rhythm that was similar to that when RFA terminates AF. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
3. Images in cardiovascular medicine. Echocardiographic demonstration of electrical alternans.
- Author
-
Billakanty S and Bashir R
- Published
- 2006
4. Atrial fibrillation symptom reduction and improved quality of life following the hybrid convergent procedure: a CONVERGE trial subanalysis.
- Author
-
Gill J, Crossen KJ, Blauth C, Kerendi F, Oza SR, Magnano AR, Mostovych MA, Halkos ME, Tschopp D, Osorio J, Tabereaux P, Boedefeld W, Civello K, Ahsan S, Yap J, Billakanty S, Duff S, Costantini O, Espinal E, Kiser A, Shults C, Pederson D, Garrison J, Gilligan DM, Link MG, Kowalski M, Stees C, Sperling JS, Jacobowitz I, Yang F, Greenberg YJ, and De Lurgio DB
- Abstract
Background: CONVERGE was a prospective, multicenter, randomized controlled trial that evaluated the safety of Hybrid Atrial Fibrillation Convergent (HC) and compared its effectiveness to endocardial catheter ablation (CA) for the treatment of persistent atrial fibrillation (PersAF) and longstanding PersAF (LSPAF). In 2020, we reported that CONVERGE met its primary safety and effectiveness endpoints. The primary objective of the present study is to report CONVERGE trial results for quality of life (QOL) and Class I/III anti-arrhythmic drug (AAD) utilization following HC., Methods: Eligible patients had drug-refractory symptomatic PersAF or LSPAF and a left atrium diameter ≤6.0 cm. Enrolled patients were randomized 2:1 to receive HC or CA. Atrial Fibrillation Severity Scale (AFSS) and the 36-Item Short Form Health Survey (SF-36) were assessed at baseline and 12 months; statistical comparison was performed using paired t -tests. AAD utilization at baseline through 12 and 18 months post-procedure was evaluated; statistical comparison was performed using McNemar's tests., Results: A total of 153 patients were treated with either HC (n=102) or CA (n=51). Of the 102 HC patients, 38 had LSPAF. AFSS and SF-36 Mental and Physical Component scores were significantly improved at 12 months versus baseline with HC overall and for the subset of LSPAF patients treated with either HC or CA. The proportion of HC patients (n=102) who used Class I /III AADs at 12 and 18 months was significantly less (33.3% and 36.3%, respectively) than baseline (84.3%; P<0.001). In LSPAF patients who underwent HC (n=38), AADs use was 29.0% through 18 months follow-up versus 71.1% at baseline (P<0.001)., Conclusions: HC reduced AF symptoms, significantly improved QOL, and reduced AAD use in patients with PersAF and LSPAF., Clinicaltrialsgov Identifier: NCT01984346., Competing Interests: Conflicts of Interest: J.G. reports research funding from Abbott and lecture honoraria from AtriCure. C.B. has consulted for New Cardioplegia Solutions as well as proctoring for AtriCure. F.K. has received research grants from AtriCure; he has consulted for CryoLife, Edwards, LivaNova, and Medtronic. S.R.O. has consulted for Biosense Webster and has received compensation for services from AtriCure. M.A.M. has received compensation for services from AtriCure. M.E.H. reports advisory board membership and consultant fees from Medtronic. D.T. has received compensation for services from AtriCure. J.O. has consulted for Biosense Webster and Boston Scientific and has received compensation for services from AtriCure. S.A. reports speaker bureau membership for AtriCure. A.K. reports advisory board membership and consultant fees from AtriCure. C.S. reports consultant fees and honoraria from Abbott Laboratories, AtriCure, and Medtronic. D.M.G. has received compensation for services from AtriCure. M.K. reports consultant fees from Medtronic. I.J. reports advisory board membership and consultant fees from AtriCure. F.Y. reports advisory board membership and consultant fees from AtriCure. D.B.D.L. is a consultant and speaker for AtriCure and Boston Scientific, and a consultant to Medtronic. The other authors have no conflicts of interest to declare., (2024 Annals of Cardiothoracic Surgery. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion.
- Author
-
Robinson A, Billakanty S, Fu E, and Amin A
- Published
- 2024
- Full Text
- View/download PDF
6. Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: A subanalysis of the CONVERGE Trial.
- Author
-
DeLurgio DB, Blauth C, Halkos ME, Crossen KJ, Talton D, Oza SR, Magnano AR, Mostovych MA, Billakanty S, Duff S, Stees C, Sperling J, Ahsan S, Yap J, Shults C, Pederson D, Garrison J, Tabereaux P, Gilligan DM, Bundy G, Costantini O, Espinal E, La Pietra A, Yang F, Greenberg Y, Jacobowitz I, and Gill J
- Abstract
Background: Favorable clinical outcomes are difficult to achieve in long-standing persistent atrial fibrillation (LSPAF) with catheter ablation (CA). The CONVERGE (Convergence of Epicardial and Endocardial Ablation for the Treatment of Symptomatic Persistent Atrial FIbrillation) trial evaluated the effectiveness of hybrid convergent (HC) ablation vs endocardial CA., Objective: The study sought to evaluate the safety and effectiveness of HC vs CA in the LSPAF subgroup from the CONVERGE trial., Methods: The CONVERGE trial was a prospective, multicenter, randomized trial that enrolled 153 patients at 27 sites. A post hoc analysis was performed on LSPAF patients. The primary effectiveness was freedom from atrial arrhythmias off new or increased dose of previously failed or intolerant antiarrhythmic drugs (AADs) through 12 months. The primary safety endpoint was major adverse event incidence through 30 days with HC. Key secondary effectiveness measures included (1) percent of patients achieving ≥90% AF burden reduction vs baseline and (2) AF freedom., Results: Sixty-five patients (42.5% of total enrollment) had LSPAF; 38 in HC and 27 in CA. Primary effectiveness was 65.8% (95% confidence interval [CI] 50.7%-80.9%) with HC vs 37.0% (95% CI 5.1%-52.4%) with CA ( P = .022). Through 18 months, these rates were 60.5% (95% CI 50.0%-76.1%) with HC vs 25.9% (95% CI 9.4%-42.5%) with CA ( P = .006). Secondary effectiveness rates were higher than CA with HC at 12 and 18 months. Freedom from atrial arrhythmias off AADs was 52.6% (95% CI 36.8%-68.5%) and 47.4% (95% CI 31.5%-63.2%) with HC at 12 and 18 months vs 25.9% (95% CI 9.4%-42.5%) and 22.2% (95% CI 6.5%-37.9%) with CA, respectively (12 months: P = .031; 18 months: P = .038). Three (7.9%) major adverse events occurred within 30 days of HC., Conclusion: Post hoc analysis demonstrated effectiveness and acceptable safety of HC compared with CA in LSPAF., (© 2022 Heart Rhythm Society. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
7. Same-day Discharge after Subcutaneous Implantable Cardioverter-defibrillator Implantation is Safe and Cost-effective.
- Author
-
Swinning J, Fox K, Billakanty S, Brown S, Chopra N, Fu E, James J, Kidwell G, Kleman J, Murnane V, Nelson S, Nichols A, Nichols SK, Robinson A, and Amin A
- Abstract
The feasibility and safety of same-day discharge after transvenous implantable cardioverter-defibrillator implantation is well-established. However, subcutaneous ICDs (S-ICDs) are now increasingly being implanted, and the feasibility, safety, and potential cost savings associated with same-day discharge after S-ICD placement has not been widely investigated. In a small cohort of patients (n = 24) who underwent S-ICD implantation at our institution, 54% were successfully discharged on the same day as their implant procedure. Procedure-related complications were not apparent in this sampling and the reduction in health care costs was high, suggesting this protocol has immense benefit in today's health care environment. As such, same-day discharge of S-ICD patients is appropriate to consider and should receive further attention., Competing Interests: The authors report no conflicts of interest for the published content. A poster of this study was previously presented at the Heart Rhythm Congress, Birmingham, UK in October 2019., (Copyright: © 2020 Innovations in Cardiac Rhythm Management.)
- Published
- 2020
- Full Text
- View/download PDF
8. Inadvertent electrical isolation of the left atrial appendage during catheter ablation of persistent atrial fibrillation.
- Author
-
Chan CP, Wong WS, Pumprueg S, Veerareddy S, Billakanty S, Ellis C, Chae S, Buerkel D, Aasbo J, Crawford T, Good E, Jongnarangsin K, Ebinger M, Bogun F, Pelosi F, Oral H, Morady F, and Chugh A
- Subjects
- Atrial Fibrillation physiopathology, Electrophysiologic Techniques, Cardiac, Female, Humans, Male, Middle Aged, Treatment Outcome, Atrial Appendage injuries, Atrial Fibrillation surgery, Catheter Ablation methods
- Abstract
Background: Left atrial appendage (LAA) isolation is rare and may be associated with impaired transport function and thromboembolism., Objective: The purpose of this study was to determine the mechanisms of inadvertent isolation of the LAA during atrial fibrillation (AF) ablation., Methods: This study consisted of 11 patients (ejection fraction 0.43 +/- 0.18, left atrial diameter 51 +/- 8 mm) with persistent AF who had LAA conduction block during a procedure for AF (n = 8) or atrial tachycardia (AT) (n = 3)., Results: LAA conduction block occurred during ablation at the Bachmann bundle region in 6 patients, mitral isthmus in 3, LAA base in 2, and coronary sinus in 1. The mean distance from the ablation site to the LAA base was 5.0 +/- 1.9 cm. LAA isolation was transient in all 6 patients in whom LAA conduction was monitored and was permanent in the 4 patients in whom conduction was not monitored during energy delivery. The remaining patient was noted to have LAA isolation during a redo procedure before any ablation. Nine of (82%) the 11 patients have remained arrhythmia-free without antiarrhythmic drugs at mean follow-up of 6 +/- 7 months, and all have continued taking warfarin., Conclusion: Electrical isolation of the LAA may occur during ablation of persistent AF and AT even when the ablation site is remote from the LAA. This likely is due to disruption of the Bachmann bundle and its leftward extension, which courses along the anterior left atrium and bifurcates to surround the LAA. Monitoring of LAA conduction during ablation of persistent AF or AT is important in avoiding permanent LAA isolation.
- Published
- 2010
- Full Text
- View/download PDF
9. 1:1 AV tachycardia: what is the mechanism?
- Author
-
Billakanty S, Chen-Scarabelli C, McLemore-McGregor R, and Jongnarangsin K
- Subjects
- Diagnosis, Differential, Humans, Male, Middle Aged, Electrocardiography methods, Tachycardia, Atrioventricular Nodal Reentry diagnosis
- Published
- 2009
- Full Text
- View/download PDF
10. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.
- Author
-
Oral H, Chugh A, Yoshida K, Sarrazin JF, Kuhne M, Crawford T, Chalfoun N, Wells D, Boonyapisit W, Veerareddy S, Billakanty S, Wong WS, Good E, Jongnarangsin K, Pelosi F Jr, Bogun F, and Morady F
- Subjects
- Electrophysiology, Female, Heart Atria physiopathology, Humans, Male, Middle Aged, Reoperation, Time Factors, Treatment Outcome, Atrial Fibrillation physiopathology, Atrial Fibrillation surgery, Catheter Ablation, Pulmonary Veins surgery
- Abstract
Objectives: This study sought to determine whether ablation of complex fractionated atrial electrograms (CFAEs) after antral pulmonary vein isolation (APVI) further improves the clinical outcome of APVI in patients with long-lasting persistent atrial fibrillation (AF)., Background: Ablation of CFAEs has been reported to eliminate persistent AF. However, residual pulmonary vein arrhythmogenicity is a common mechanism of recurrence., Methods: In this randomized study, 119 consecutive patients (mean age 60 +/- 9 years) with long-lasting persistent AF underwent APVI with an irrigated-tip radiofrequency ablation catheter. Antral pulmonary vein isolation resulted in termination of AF in 19 of 119 patients (Group A, 16%). The remaining 100 patients who still were in AF were randomized to no further ablation and underwent cardioversion (Group B, n = 50) or to ablation of CFAEs in the left atrium or coronary sinus for up to 2 additional hours of procedure duration (Group C, n = 50)., Results: Atrial fibrillation terminated during ablation of CFAEs in 9 of 50 patients (18%) in Group C. At 10 +/- 3 months after a single ablation procedure, 18 of 50 (36%) in Group B and 17 of 50 (34%) in Group C were in sinus rhythm without antiarrhythmic drugs (p = 0.84). In Group A, 15 of 19 patients (79%) were in sinus rhythm. A repeat ablation procedure was performed in 34 of 100 randomized patients (for AF in 30 and atrial flutter in 4). At 9 +/- 4 months after the final procedure, 34 of 50 (68%) in Group B and 30 of 50 (60%) in Group C were in sinus rhythm without antiarrhythmic drugs (p = 0.40)., Conclusions: Up to 2 h of additional ablation of CFAEs after APVI does not appear to improve clinical outcomes in patients with long-lasting persistent AF.
- Published
- 2009
- Full Text
- View/download PDF
11. Radiofrequency catheter ablation of AV nodal reentrant tachycardia in situs inversus totalis.
- Author
-
Billakanty S, Crawford T, Good E, and Oral H
- Subjects
- Adult, Humans, Male, Treatment Outcome, Catheter Ablation methods, Situs Inversus complications, Situs Inversus surgery, Tachycardia, Atrioventricular Nodal Reentry complications, Tachycardia, Atrioventricular Nodal Reentry surgery
- Abstract
A 41-year-old male with situs inversus totalis had paroxysmal supraventricular tachycardia. On electrophysiology study, the mechanism of the tachycardia was determined as slow/fast atrioventricular nodal reentrant tachycardia and slow pathway was successfully performed under fluoroscopic guidance.
- Published
- 2009
- Full Text
- View/download PDF
12. Relationship between the spectral characteristics of atrial fibrillation and atrial tachycardias that occur after catheter ablation of atrial fibrillation.
- Author
-
Yoshida K, Chugh A, Ulfarsson M, Good E, Kuhne M, Crawford T, Sarrazin JF, Chalfoun N, Wells D, Boonyapisit W, Veerareddy S, Billakanty S, Wong WS, Jongnarangsin K, Pelosi F Jr, Bogun F, Morady F, and Oral H
- Subjects
- Atrial Fibrillation physiopathology, Body Surface Potential Mapping methods, Catheter Ablation methods, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Monitoring, Intraoperative methods, Prognosis, Signal Processing, Computer-Assisted, Tachycardia, Ectopic Atrial diagnosis, Tachycardia, Ectopic Atrial physiopathology, Atrial Fibrillation surgery, Catheter Ablation adverse effects, Tachycardia, Ectopic Atrial etiology
- Abstract
Background: During catheter ablation of complex fractionated atrial electrograms, persistent atrial fibrillation (AF) may convert to an atrial tachycardia (AT)., Objective: The purpose of this study was to investigate the possible mechanisms of AT by examining the spectral and electrophysiologic characteristics of AF and ATs that occur after catheter ablation of AF., Methods: The subjects of this study were 33 consecutive patients with persistent AF who had conversion of AF to AT during ablation of AF (group I) and 20 consecutive patients who underwent ablation of persistent AT that developed more than 1 month after AF ablation (group II). Spectral analysis of the coronary sinus (CS) electrograms and lead V(1) was performed during AF at baseline, before conversion, and during AT. The spatial relationship between the AT mechanism and ablation sites was examined., Results: A spectral component with a frequency that matched the frequency of AT was present in the baseline periodogram of AF more often in group I (52%) than in group II (20%, P = .02). Ablation resulted in a decrease in the dominant frequency of AF but not in the frequency of the spectral component that matched the AT. There was a significant direct relationship between the baseline dominant frequency of AF and the frequency of AT in the CS in group I (r = 0.76, P <.0001) but not in group II (r = 0.38, P = .09). ATs were macroreentrant in 64% and 60% of patients in groups I and II, respectively (P = .8). The AT site was more likely to be distant (>1 cm) from AF ablation sites in group I (70%) than in group II (35%, P = .007)., Conclusion: The findings of this study suggest that ATs observed during ablation of AF often may be drivers of AF that become manifest after elimination of higher-frequency sources and fibrillatory conduction.
- Published
- 2009
- Full Text
- View/download PDF
13. Prevalence and characteristics of continuous electrical activity in patients with paroxysmal and persistent atrial fibrillation.
- Author
-
Tada H, Yoshida K, Chugh A, Boonyapisit W, Crawford T, Sarrazin JF, Kuhne M, Chalfoun N, Wells D, Dey S, Veerareddy S, Billakanty S, Wong WS, Kalra D, Kfahagi A, Good E, Jongnarangsin K, Pelosi F Jr, Bogun F, Morady F, and Oral H
- Subjects
- Atrial Fibrillation epidemiology, Female, Follow-Up Studies, Heart Atria physiopathology, Humans, Male, Middle Aged, Prevalence, Prognosis, Severity of Illness Index, Tachycardia, Paroxysmal epidemiology, Atrial Fibrillation physiopathology, Electrocardiography, Heart Conduction System physiopathology, Tachycardia, Paroxysmal physiopathology
- Abstract
Background: Complex fractionated atrial electrograms (CFAEs) may play a role in the genesis of atrial fibrillation (AF). One type of CFAE is continuous electrical activity (CEA). The prevalence and characteristics of CEA in patients with paroxysmal and persistent AF are unclear., Methods and Results: In 44 patients (age = 59 +/- 8 years) with paroxysmal (25) or persistent (19) AF, bipolar electrograms were systematically recorded for > or =5 seconds at 24 left atrial (LA) sites, including 8 antral sites, and 2 sites within the coronary sinus (CS). CEA was defined as continuous depolarization for >1 second with no isoelectric interval. CEA was recorded at the LA septum (79%), antrum (66%), posterior (68%) and anterior walls (67%), roof (66%), base of the LA appendage (61%), inferior wall (61%), posterior mitral annulus (48%), CS (41%), and in the LA appendage (14%). Antral CEA was equally prevalent in patients with paroxysmal (63%) and persistent AF (70%, P = 0.12). In patients with paroxysmal AF, the prevalence of CEA was similar among antral and nonantral LA sites, except for the LA appendage. However, in patients with persistent AF, CEA was more prevalent at the nonantral (80%) than antral sites (70%, P = 0.03). CEA at nonantral sites except the CS was more prevalent in persistent than in paroxysmal AF (80% vs 57%, P < 0.001). The mean duration of intermittent episodes of CEA was longer in persistent than in paroxysmal AF (P < 0.001)., Conclusions: The higher prevalence and duration of CEA at nonantral sites in persistent than in paroxysmal AF is consistent with a greater contribution of LA reentrant mechanisms in persistent AF. However, the high prevalence of CEA at nonantral sites in paroxysmal atrial fibrillation (PAF) suggests that CEA alone is a nonspecific marker of appropriate target sites for ablation of AF. The characteristics of CEA that most accurately identify drivers of AF remain to be determined.
- Published
- 2008
- Full Text
- View/download PDF
14. May-Thurner syndrome: A vascular abnormality encountered during electrophysiologic study.
- Author
-
Billakanty S, Burket MW, and Grubb BP
- Subjects
- Adult, Female, Humans, Phlebography, Rare Diseases diagnosis, Syndrome, Electrocardiography methods, Iliac Vein abnormalities, Iliac Vein diagnostic imaging, Peripheral Vascular Diseases diagnosis, Venous Thrombosis diagnosis
- Abstract
In the course of clinical practice the electrophysiologist may encounter a variety of vascular abnormalities which are important to recognize, as they may impact upon the health and welfare of the patient. We describe a case of iliac vein compression (May-Thurner) syndrome and review its etiology, diagnosis, significance, and treatment.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.